Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.53B
Enterprise Value9.03B
P/E Ratio19.7
PEG Ratio1.01
Price/Sales Ratio2.32
Price/Book Ratio1.61
Enterprise/Revenue2.65
Enterprise/EBITDA13.39

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.12
Operating Margin0.14
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.08

Income Statement

Revenue3.4B
Revenue/Share7.5
Gross Profit1.4B
EBITDA729.46M
Net Income400.51M
Diluted EPS0.88

Balance Sheet

Total Cash1.68B
Total Cash/Share3.7
Total Debt1.68B
Total Debt/Equity0.35
Current Ratio1.81
Book Value Per Share11.61

Price History

52-Week Change-21.13
52-Week High24.03
52-Week Low13.91
Moving Average 50 Days15.73
Moving Average 200 Days18.35

Statistics

Average Volume3.85M
Shares Outstanding464.75M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.4
Trailing Annual Dividend Yield2.35
Payout Ratio0.75
Last Split Factor1993579:1000000
Last Split DateApril 22, 2014
AD